Skip to main content
Clinical Trials/IRCT20151017024572N23
IRCT20151017024572N23
Not yet recruiting
Phase 3

ltrasound-guided Prolotherapy, Oxygen-ozone and corticosteroid injection for treatment of knee osteoarthritis: A randomized, double-blind, multi-center study.

Iran University of Medical Sciences0 sites42 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Osteoarthritis of knee.
Sponsor
Iran University of Medical Sciences
Enrollment
42
Status
Not yet recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with mild to moderate osteoarthritis of the knee (Kellgren Lawrence grade I, II and III)
  • Knee pain for at least six months

Exclusion Criteria

  • History of knee surgery or fracture
  • History of knee meniscus or ligaments tear (ACL/PCL/MCL/LCL)
  • History of allergic reaction to Corticosteroid, Dextrose or Ozone
  • Infection at the injection site
  • Uncontrolled diabetes
  • History of systemic inflammatory or connective tissue disease
  • History of knee injections in the last three months
  • History of gout
  • Secondary knee osteoarthritis
  • Contraindications of ozone therapy (deficiency G6PD, uncontrolled hyperthyroidism, leukemia)

Outcomes

Primary Outcomes

Not specified

Similar Trials